Enhancing identification and treatment of patients with concomitant chronic venous insufficiency and diabetes mellitus A modified Delphi study from the CODAC (ChrOnic venous disease and Diabetes Advisory Council) group

BOZKURT A. K., van Rijn M. J., Bouskela E., Gastaldi G., Glauser F., Haller H., ...Daha Fazla

International Angiology, cilt.42, sa.5, ss.427-435, 2023 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 42 Sayı: 5
  • Basım Tarihi: 2023
  • Doi Numarası: 10.23736/s0392-9590.23.05061-7
  • Dergi Adı: International Angiology
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, EMBASE
  • Sayfa Sayıları: ss.427-435
  • Anahtar Kelimeler: Consensus, Diabetes mellitus, Venous insufficiency
  • İstanbul Üniversitesi Adresli: Hayır

Özet

A B S T R A C T Background: Chronic venous insufficiency (CVI) and diabetes mellitus (DM) pose significant burdens to patients and healthcare systems. While the two diseases share a number of commonalities in risk factors and pathophysiology, they are often assessed and managed separately. This can lead to a worsening of comorbidities and limitations in a patient’s quality of life. This project aims to develop recommendations to enhance the identification and treatment of patients with concomitant CVI and DM. Methods: Using a modified Delphi method, a panel of experts developed 38 Likert Scale and two multiple choice questions across six key themes. These were used to form an online survey which was disseminated through a convenience sampling approach to CVI and DM healthcare professionals across Europe, Central America, South America, and the Middle East. The threshold for consensus was set at ≥75%. Results: A total of 238 responses were received. 27/38 statements attained >90% agreement, nine of 38 attained between 75-90%, and two failed to meet the threshold (<75%). The awareness around the impact of the two diseases was high, but a gap was highlighted in the identification of patients with concomitant CVI and DM. Conclusions: The high level of agreement shows that healthcare professionals are aware of the gaps in identification and treatment of patients with concomitant CVI and DM, and of the need to approach this as a combined therapy area. An algorithm is proposed to help the identification of at-risk patients and to provide recommendations on the management of patients with concomitant disease. (Cite this article as: Bozkurt AK, van Rijn MJ, Bouskela E, Gastaldi G, Glauser F, Haller H, et al. Enhancing identification and treatment of patients with concomitant chronic venous insufficiency and diabetes mellitus. A modified Delphi study from the CODAC (ChrOnic venous disease and Diabetes Advisory Council) group. Int Angiol 2023;42:427-35. DOI: 10.23736/S0392-9590.23.05061-7)